Real world ablation therapy with anticoagulants in management of atrial fibrillation

Real world ablation therapy with anticoagulants in management of atrial fibrillation - RYOUMA Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026092

Enrollment

3000

Registered

2017-02-10

Start date

2017-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Valvular Atrial Fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria at the time of giving informed consent are eligible as subjects of this study. (1) Patients with a diagnosis of NVAF. (2) Patients scheduled to undergo catheter ablation

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded from this study. (1) It is impossible to obtain written informed consent from the patient or a legal representative. (2) Current or scheduled participation in a clinical trial involving pharmacotherapy (3) Not the first catheter ablation (3) Any other reason that disqualifies the patient from participating in this study in the investigator's opinion

Design outcomes

Primary

Measure	Time frame
The overall incidence of adverse events during the follow-up period.	—

Countries

Japan

Contacts

Public ContactKazushuge Oishi

Mediscience Planning Inc. Medical Information Div.

info-ryouma@mpi-cro.jp03-5820-7026

Outcome results